Collegium Pharmaceutical Inc (COLL) — Cash Flow Reinvestment Rate
Collegium Pharmaceutical Inc (COLL) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting $31.06 Million (capex $188.00K plus investments $-30.87 Million) from operating cash flow of $78.44 Million. See how much free cash does Collegium Pharmaceutical Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Collegium Pharmaceutical Inc Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Collegium Pharmaceutical Inc across 7 annual periods. For the full cash flow conversion analysis, see Collegium Pharmaceutical Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Collegium Pharmaceutical Inc (2018–2024)
Year-by-year capital reinvestment analysis for Collegium Pharmaceutical Inc. See Collegium Pharmaceutical Inc (COLL) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $289.41 Million | $204.98 Million | $1.65 Million | ▲ +723.3% |
| 2023 | 0.17x | $47.12 Million | $274.75 Million | $461.00K | ▼ -96.3% |
| 2022 | 4.63x | $575.31 Million | $124.23 Million | $1.62 Million | ▲ +12234.8% |
| 2021 | 0.04x | $3.89 Million | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 7.96x | $747.54 Million | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.46x | $12.88 Million | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.29x | $48.71 Million | $169.39 Million | $24.35 Million | — |